Pay in installments of $6.93 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Semaglutide: Semaglutide Side Effects: Risk of Vision Loss Delhi News Times of India semaglutide diarrhea legal team in kentucky Semaglutide Lexington KY FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in the U.S. drug supply chain. The agency recently seized dozens of units of counterfeit Ozempic (semaglutide) injection 1 mg that were hims glp 1 weight loss reviews GLP 1 ad battle: Ozempic and Wegovy maker on the Hims & Hers Super Bowl ad Why Ozempic Doesn't Work for Some People: Unlocking Your Unique Path to Weight Loss PlexusDx
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.5 ★★★★★
Based on 21 reviews
Sort
Product Reviews
★★★★★ 4
Slow, sorry but good
Format: Kindle
This was a slow moving book. Lots of character pov chapters, lots of superfluous descriptions and endless courtly appearances stalled this book to start. Once you get into the heart of the story, it takes off. Before you know it the book is done. My favorite character is Reyna. She is so strong. She is true to herself. She gets into a lot of trouble with her headstrong ways but it's entertaining. I have high hopes for Lorcan. He is honorable to a fault. Thane had turned out to be better than I thought but i still don't like him. Eislin is useless. Great plot twists at the end. I'm looking forward too book 2.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 6, 2020
★★★★★ 5
Very detailed! Beautiful world building! Strong Heroine!
Format: Kindle
Starts off a little slow and confusing with different POV’s, but starts to all come together towards the middle to make an elaborate plot line and makes it all worth it. Beautiful world building and attention to detail as well as great writing. The cliffhanger was gut wrenching! Can’t wait for the next book!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 4, 2020
★★★★★ 4
Interesting
Format: Kindle
This was a very captivating book once you got into it thoroughly. But the third person perspective was a bit hard to get used to. But as you got into it and followed the different characters, it was interesting and filled with intrigue, conflict and forbidden love.
I can’t wait to read the next one and to complete the series.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 12, 2022
★★★★★ 5
LOVED THIS STORY!
Format: Kindle
I never wite reviews, but this book was too good for me to NOT give props and let others readers know it's such a good read. They need to make movies of this one and I can't wait until the next book comes out. The story building was so good and I loved that the main character wasn't a silly useless princess or something. Shes intelligent, strong, and loves her friends. The description of the characters is really good also and its such a good plot. Not your average paranormal romance novel of some princess or the girl working at a diner. LOL! I'm totally team Rykan for her! Fingers crossed for the next book and October 31st can't come soon enough.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 15, 2023
★★★★★ 4
Imperfect characters
Format: Kindle
4.5 stars ⭐
I don't really understand the harsh criticism in some of these reviews (Goodreads). I rarely write reviews myself, but I think this book deserves it.
Look, it absolutely has its issues. I wasn't feeling it in the beginning -- the first few chapters were all tell and no show, literally just telling us all this background in a few paragraphs rather than feeding us bits and pieces at a time. The writing significantly improves after a few chapters, though. And I didn't catch any spelling or grammatical typos often found in new, self published books.
After the rough start, I absolutely flew through the rest of the book and couldn't put it down. Seriously stayed up until 2am with it. So I also don't agree with comments calling it boring. Definitely did not bore me. I thought it ticked all the right boxes: romance, fantasy, a magic system, tragedy, fate, character growth.
A lot of the poor reviews I'm seeing are in regards to the FMC's character. Personally, I like flawed characters and think it's more realistic than reading the POV of someone who always makes the right decisions, is always honest, is always selfless, etc. Humans aren't like that. Readers love when male leads are morally grey, but God forbid a woman isn't perfect.
So I like flawed characters and I like a little bit of tragedy, which the author provides. Ends on a cliffhanger, and I can't wait to read the sequel next month. I really want to learn more about Malachi.
All in all, not a bad start from this author. Give it a chance.
SOMEWHAT SPOILERY:
I LOVE the concept of fated mates that kind of hate each other. Most books with the fated mates trope allow the characters to immediately fall for each other and get together relatively easily. But this is way more interesting ;)
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 1, 2023
recommand products
Glucagon-like peptide-1 receptors in the kidney: impact on renal autoregulation | American Journal of Physiology-Renal Physiology
25.74
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
23.56
GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists
26.66
Potential GLP-1 independent mechanisms of DPP-4 inhibition with
21.27
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
23.07